Celularity to also participate in a fireside chat and panel discussion with Dr. Scott Gottlieb
FLORHAM PARK, N.J., March 09, 2021 (GLOBE NEWSWIRE) — Celularity Inc. (“Celularity”), a clinical-stage biotechnology company focused on the development of innovative allogeneic placenta-derived cellular therapies, announced that Robert J. Hariri, M.D., Ph.D., founder, Chairperson and Chief Executive Officer of Celularity, will present a corporate overview as well as participate in a fireside chat and panel discussion during the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021.
Corporate Presentation
A pre-recorded presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. ET on March 9, 2021.
Fireside Chat
Topic: Novel Approaches to Allogeneic Cell-Based Immunotherapy: Disruptive Applications in Oncology and Beyond
Date: March 10, 2021
Time: 12:00-1:00 p.m. ET
Panel on Gene and Cell Therapies with Dr. Scott Gottlieb
Date: March 10, 2021
Time: 3:00-4:30 p.m. ET
Webcast: Link
A video recording of the corporate presentation will be available on the “Newsroom” section of the Celularity website following the conference.
About Celularity
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placenta-derived allogeneic cell therapies, including genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address a significant unmet global need for effective, accessible, and affordable therapeutics. To learn more visit celularity.com.
Celularity Investor Contacts:
Carlos Ramirez
Celularity
carlos.ramirez@celularity.com
Alexandra Roy
Solebury Trout
aroy@troutgroup.com
Celularity Media Contact
Jason Braco, Ph.D.
LifeSci Communications
(646)-751-4361
jbraco@lifescicomms.com
Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…
A Revolutionary ATCA/VME/VXI 3D-Flow Board: 512 Channels, >2,800 Programmable Operations—Scalable to >50,000 Operations on Each…
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…